(Q35183767)

7 August 2017

1 reference

title

Acute promyelocytic leukaemia:a review (English)

1 reference

7 August 2017

1 reference

2

Martin S Tallman

1 reference

7 August 2017

Simrit Parmar

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

1379-1392

1 reference

The World Health Organization (WHO) classification of the myeloid neoplasms

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Acute promyelocytic leukemia. M.D. Anderson Hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

PML is essential for multiple apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

The promise of retinoids to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Arsenic trioxide: acute promyelocytic leukemia and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Acute promyelocytic leukemia: a curable disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

Extramedullary acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukaemia cell line NB-4 under physiologic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.4.8.1379

10.1517/14656566.4.8.1379

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference